Elsevier

The Lancet Oncology

Volume 8, Issue 2, February 2007, Pages 177-178
The Lancet Oncology

Case Report
Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma

https://doi.org/10.1016/S1470-2045(07)70037-2Get rights and content

References (10)

There are more references available in the full text version of this article.

Cited by (127)

  • Anticancer Drugs and the Kidney

    2019, Critical Care Nephrology: Third Edition
  • Thrombotic microangiopathy and cancer

    2017, Nephrologie et Therapeutique
  • Thrombotic Microangiopathy, Cancer, and Cancer Drugs

    2015, American Journal of Kidney Diseases
View all citing articles on Scopus
View full text